Endocarditis as a Marker for New Epidemics of Injection Drug Use
- PMID: 27916216
- PMCID: PMC5482229
- DOI: 10.1016/j.amjms.2016.10.002
Endocarditis as a Marker for New Epidemics of Injection Drug Use
Abstract
Background: We examined discharges for infective endocarditis (IE) at an academic teaching hospital for over 10 years to evaluate if an increase in hospitalizations for IE and increase in hepatitis C virus (HCV) in patients with IE could predict a new epidemic of injection drug use (IDU).
Materials and methods: Retrospective medical record review of discharged patients with the diagnosis of IE as defined by the modified Duke criteria. Student's t test, chi-squared test and Fisher's exact test were used to calculate P values.
Results: There were 542 discharges among 392 unique patients with IE and 104 patients were readmitted 2-7 times. Of the total discharges, 367 (67.7%) were not screened for HCV, and of those tested, 86 (49.1%) were HCV+; 404 (74.5%) were not screened for HIV and of those tested, 28 (20.3%) were HIV+. Patients who self-identify as a person who injects drugs were more likely to be tested for HCV, 75 (69.4%) versus 12 (31.5%, P < 0.0001), and for HIV, 72 (66.6%) versus 13 (34.2%, P < 0.0001) compared with those who self-report no IDU. Those with a positive result for opiate or heroin toxicology test were more likely to be screened for HCV, 70 (66%) versus 22 (44.8%, P < 0.0001), and for HIV, 66 (62.2%) versus 25 (51%, P < 0.0001) than those with negative result for toxicology test. Over this period, there was a 2-fold increase in IE cases, a 3-fold increase in HCV antibody prevalence and a 6-fold increase in opiate toxicology screens showing positive result, but no increase in HIV.
Conclusions: Although IDU is a known risk factor for IE, the observation of a sharp increase in IE cases may signal a new epidemic of IDU and HCV.
Keywords: Endocarditis; Hepatitis C virus; Human immunodeficiency virus; Injection drug use.
Copyright © 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors have no financial or other conflicts of interest to disclose.
Figures
References
-
- Gordon RJ, Lowy FD. Bacterial infections in drug users. N Engl J Med. 2005;353:1945–54. - PubMed
-
- Bouza E, Menasalvas A, Munoz P. Infective endocarditis—a prospective study at the end of the twentieth century. Medicine. 2001;80:298–307. - PubMed
-
- Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware valley, 1988–1990. Am J Cardiol. 1995;76:933–6. - PubMed
-
- Hogevik H, Olaison L, Anderson R, et al. Epidemiological aspects of infective endocarditis in an urban population: a five year prospective study. Medicine. 1995;74:324–39. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
